Leveraging Pathophysiology and Context of Use to Identify NASH Clinical Trial Biomarkers Published 2020-12-15 Download video MP4 360p Download video MP4 720p Recommendations 58:17 Ask the Experts NASH and Clinical Trial 1:00:47 Optimizing PBMC and Flow Cytometry Results Webinar 17:30 Treating NASH 2023: Current and Near Future Treatments | UCLA Digestive Diseases 1:01:41 OPEN Stage Webinar: Biomarker development and validation 58:30 AAV Vector Shedding Assay—Best Practices in Clinical Gene Therapy Method Development 05:19 A Closer Look at Context of Use 02:28 Celerion’s Zurich Bioanalytical Lab Tour 48:45 2020 Evan and Bronwyn Giving Tuesday Interview 17:00 Psychosis & Schizophrenia Mnemonics (Memorable Psychiatry Lecture) 04:40 Understanding Parkinson’s Disease 47:37 Onsite Pharmacy Compounding for Your Phase 1 Clinical Study 07:46 Liver Disease Part I 30:43 Aernout van Haarst Presents Optimizing Early Clinical Trials in Special Populations 22:14 What they don't tell you about cannabis before surgery- Dr. Kaveh LIVE 3:15:38 What is ChatGPT doing...and why does it work? 1:00:13 Bioanalytical Support of Biosimilars Expect the Unexpected 3:52:21 RPA UiPath Full Course | RPA UiPath Tutorial For Beginners | RPA Course | RPA Tutorial | Simplilearn 04:43 Strategies for Maximizing Participant Recruitment in Clinical Research 04:02 Celerion’s Lincoln Bioanalytical Lab Tour 57:35 Drug Labeling Studies in Clinical Pharmacology: Recent FDA/EMA Updates Similar videos 1:01:13 Biomarkers in NASH Drug Development 13:08 Industry Perspectives on Context of Use and Biomarker Assays 09:07 Case Study: Discovery of an early diagnostic biomarker for NASH 48:30 Clinical overview of NAFL/NASH 27:51 CK18 as a Biomarker in NASH Clinical Trials 29:28 Leveraging Non-Invasive Approaches in NAFLD/NASH Diagnosis and Clinical Research 2:02:48 Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials-D1-PM 38:02 NASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes | Arun Sanyal 4:22:45 Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials-D2-PM 4:08:18 Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials-D1-AM 6:24:23 Leveraging Clinical Pharmacology to Optimize Drug Development for NASH & Cholestatic Liver Diseases2 39:25 Non-Invasive Diagnosis of Liver Fibrosis by Dr. M. Shadab Siddiqui, MD 38:52 Panel Presentation: Digital Solutions to Alleviate NASH Clinical Trial Challenges 58:06 On-Demand Webinar: High-Throughput Biomarker Discovery for Clinical Trial Optimization 21:20 Biomarkers of Effect Webinar Introduction 2:26:33 Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials-D2-AM 3:28:05 Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 1 16:18 S3-E30.1 - Highlighting Intriguing #ILC2022 Abstracts: Machine Learning Identified NASH Biomarkers 1:25:46 Biomarkers of Effect Webinar Panel Discussion More results